Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

Market Cap	650.67B +19.9%
Revenue (ttm)	231.90B +7.6%
Net Income	-3.71B
EPS	-74.01
Shares Out	51.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	185,554
Average Volume	174,096
Open	12,640
Previous Close	12,600
Day's Range	12,410 - 12,660
52-Week Range	6,400 - 20,500
Beta	1.35
RSI	40.69
Earnings Date	Mar 20, 2026

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1962
• Employees: 809
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 019170

Financial Performance

In 2024, KRX:019170's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.